JP

Judy Pagliuca

North America, United States

Description

Founding Partner

Investor Profile

Judy Pagliuca has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Therapeutics.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Judy Pagliuca frequently co-invest with?

Arranta Bio
North America, Massachusetts, United States, Watertown
Co-Investments: 1
Pillar VC
North America, Massachusetts, United States, Boston
Co-Investments: 1
NV
North America, Massachusetts, United States, Boston
Co-Investments: 1

Which angels does Judy Pagliuca often collaborate with?

JM
North America, Massachusetts, United States, Boston
Shared Deals: 1
PR
North America, Massachusetts, United States, Boston
Shared Deals: 1
GC
North America, Massachusetts, United States, Boston
Shared Deals: 1
MB
North America, Massachusetts, United States, Boston
Shared Deals: 1

What are some of recent deals done by Judy Pagliuca?

Thymmune Therapeutics

Cambridge, Massachusetts, United States

Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform.

BiotechnologyTherapeutics
SeedMar 1, 2023
Amount Raised: $7,000,000